InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Glickman Richard M. Officer active across 2 companies, notably enGene Holdings Inc.. Cumulatively, 4 filings have been recorded. History available since 24 April 2024. The latest transaction was filed on 28 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant with 4 filings in total, associated with ESSA Pharma Inc. and enGene Holdings Inc. as Director. Among the sampled recent filings, the modal transaction nature is Option exercise, with a period running from 2023-11-02 to 2025-10-15.